Risk classification guide for drug good manufacturing practices observations (GUI0023), (February 28, 2018)을 발표 했다.
-내용-
This document helps ensure consistency among Health Canada inspectors during drug establishment inspections when:
classifying good manufacturing practices (GMP) observations according to risk.
assigning an overall compliance rating to an inspection or to the paper review of GMP evidence.
It also informs industry of the situations Health Canada considers unacceptable that may result in a non-compliant (NC) rating and/or compliance and enforcement actions
-원문-
Risk classification guide for drug good manufacturing practices observations (GUI0023), (February 28, 2018)을 발표 했다.
-내용-
This document helps ensure consistency among Health Canada inspectors during drug establishment inspections when:
classifying good manufacturing practices (GMP) observations according to risk.
assigning an overall compliance rating to an inspection or to the paper review of GMP evidence.
It also informs industry of the situations Health Canada considers unacceptable that may result in a non-compliant (NC) rating and/or compliance and enforcement actions
-원문-
CONTACT
대표자 : 이상건 | 사업자등록번호 : 454-81-00389
주소 : 경기도 안양시 동안구 경수대로651번길 58-2, 1층 (호계동)
Tel : 031-386-9433 | Fax : 031-386-9436
E-mail : hk@hkems.co.kr
CONTACT
대표자 : 이상건 | 사업자등록번호 : 454-81-00389
주소 : 경기도 안양시 동안구 경수대로651번길 58-2,
1층 (호계동)
Tel : 031-386-9433 | Fax : 031-386-9436
E-mail : hk@hkems.co.kr